RecruitingPhase 4NCT05776953

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic

Sponsor

Hackensack Meridian Health

Enrollment

86 participants

Start Date

Dec 21, 2023

Study Type

INTERVENTIONAL

Conditions

Analgesia Emergencies Renal Colic Flank Pain

Summary

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

Patients will be included if they present to the Emergency Department with (all of the following):
Adult emergency department patients \< 65 years old
One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or right lower quadrant pain, and/or pelvic pain
Pain score of 4 or greater on the 0-10 NRS
Determination of treatment with IV ketorolac

Exclusion Criteria8

Patients will be excluded if any of the following apply:
Allergy to ketorolac
Pregnant patients
Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
Known or stated history of renal insufficiency
Body weight \< 50 kg
Age greater than 65 years
Patients that do no read/write Spanish or English

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.